Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124737332 | 12473733 | 2 | F | 201607 | 20160722 | 20160616 | 20160728 | EXP | US-ABBVIE-16P-163-1651318-00 | ABBVIE | 63.15 | YR | M | Y | 0.00000 | 20160728 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124737332 | 12473733 | 1 | PS | VIEKIRA PAK | DASABUVIROMBITASVIRPARITAPREVIRRITONAVIR | 1 | Oral | UNKNOWN,153307 | 206619 | TABLET | BID | ||||||||
| 124737332 | 12473733 | 2 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | 2 (400MG)AM, 3 (600MG)PM | 0 | ||||||||||
| 124737332 | 12473733 | 3 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | 2 PILLS AM, 1 PILL PM | 0 | ||||||||||
| 124737332 | 12473733 | 4 | C | CHLOROPHYLL | 2 | 0 | |||||||||||||
| 124737332 | 12473733 | 5 | C | ZINC | ZINCINC CHLORIDE | 1 | 0 | ||||||||||||
| 124737332 | 12473733 | 6 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
| 124737332 | 12473733 | 7 | C | PROBIOTIC | PROBIOTICS NOS | 1 | 0 | ||||||||||||
| 124737332 | 12473733 | 8 | C | VITAMIN B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124737332 | 12473733 | 1 | Hepatitis C |
| 124737332 | 12473733 | 2 | Hepatitis C |
| 124737332 | 12473733 | 4 | Product used for unknown indication |
| 124737332 | 12473733 | 5 | Product used for unknown indication |
| 124737332 | 12473733 | 6 | Product used for unknown indication |
| 124737332 | 12473733 | 7 | Product used for unknown indication |
| 124737332 | 12473733 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124737332 | 12473733 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124737332 | 12473733 | Abnormal faeces | |
| 124737332 | 12473733 | Anaemia | |
| 124737332 | 12473733 | Anxiety | |
| 124737332 | 12473733 | Aphasia | |
| 124737332 | 12473733 | Asthenia | |
| 124737332 | 12473733 | Diarrhoea | |
| 124737332 | 12473733 | Dysstasia | |
| 124737332 | 12473733 | Frequent bowel movements | |
| 124737332 | 12473733 | Headache | |
| 124737332 | 12473733 | Nausea | |
| 124737332 | 12473733 | Presyncope | |
| 124737332 | 12473733 | Pyrexia | |
| 124737332 | 12473733 | Sinusitis | |
| 124737332 | 12473733 | Speech disorder | |
| 124737332 | 12473733 | Urinary tract infection | |
| 124737332 | 12473733 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124737332 | 12473733 | 1 | 20160520 | 0 | ||
| 124737332 | 12473733 | 2 | 20160609 | 0 |